COMMUNIQUÉ DE PRESSE publié le 23/01/2024 à 08:00, il y a 2 années 6 mois Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies have signed an agreement for the supply of Actinium-225 (Ac-225), a radionuclide for developing the next generation of therapeutic radiopharmaceuticals. The agreement aims to increase access to Ac-225, which is vital for advancing the development and clinical research efforts of Full-Life Technologies. Clinical Research Eckert & Ziegler Full-Life Technologies Actinium-225 Supply Agreement Therapeutic Radiopharmaceuticals
COMMUNIQUÉ DE PRESSE publié le 23/10/2023 à 09:00, il y a 2 années 9 mois Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials
COMMUNIQUÉ DE PRESSE publié le 20/10/2023 à 15:40, il y a 2 années 9 mois Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG
COMMUNIQUÉ DE PRESSE publié le 20/10/2023 à 15:18, il y a 2 années 9 mois EQS-Adhoc: Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical Assets
COMMUNIQUÉ DE PRESSE publié le 17/10/2023 à 16:57, il y a 2 années 9 mois EQS-Adhoc: Eckert & Ziegler Achieves Double-Digit Growth in Q3 versus Previous Year. Significant Jump in Sales also in First 9 Months, Earnings still Burdened by Special Items Compared to Same Period Last Year.
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 15:00, il y a 2 années 9 mois Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 10:00, il y a 2 années 10 mois Eckert & Ziegler Receives Award for Professional Training
COMMUNIQUÉ DE PRESSE publié le 25/09/2023 à 23:17, il y a 2 années 10 mois EQS-Adhoc: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma
COMMUNIQUÉ DE PRESSE publié le 13/09/2023 à 15:00, il y a 2 années 10 mois Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 07:45, il y a 2 années 11 mois Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
Publié le 29/07/2026 à 12:05, il y a 4 heures 46 minutes CNP Assurances wins the call for tenders for the personal risk insurance of 62,000 employees of the City of Paris and its partners
Publié le 29/07/2026 à 12:05, il y a 4 heures 46 minutes CNP Assurances remporte l’appel d’offres pour la prévoyance des 62 000 agents de la Ville de Paris et de ses partenaires
Publié le 29/07/2026 à 08:15, il y a 8 heures 36 minutes Winamp Announces Strategic Partnership with Deezer to Power the Next Generation of Its Iconic Music Player
Publié le 29/07/2026 à 15:01, il y a 1 heure 50 minutes Worksport Announces Q2 2026 Earnings Call and Investor Town Hall for August 11, 2026; CEO Believes Current Market Valuation Does Not Yet Fully Reflect Recent Positive Operating Progress
Publié le 29/07/2026 à 14:30, il y a 2 heures 21 minutes Stabilis Solutions Announces Second Quarter 2026 Conference Call and Webcast Date
Publié le 29/07/2026 à 13:30, il y a 3 heures 21 minutes Audited Annual Statements for the Fiscal Year Ended March 31, 2026
Publié le 29/07/2026 à 13:30, il y a 3 heures 21 minutes Sterling Drills Molybdenum Rich Breccia Below MEPS Discovery Intersecting 57 m of 0.81% CuEq Within a Near-Surface 358 m of 0.50% CuEq Including 8.5 m of 4.74% CuEq
Publié le 29/07/2026 à 13:10, il y a 3 heures 41 minutes Spirit Blockchain Capital Appoints Judy Galvez as Chief Financial Officer and Provides Corporate Update
Publié le 29/07/2026 à 16:47, il y a 4 minutes Invitation to the Earnings Call of ZEAL Network SE - Publication of the Half-Year Report 2026
Publié le 29/07/2026 à 16:07, il y a 44 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC